FundingWatcher
Home / Startups / Top health care startups / Health care startups that raised Series C / Health care startups that raised Series C in Asia

Health care startups that raised Series C in Asia

Updated 16 Nov 2026

Reset
Health care startups that raised Series C in Asia
One-time CSV
  • 461 funded companies, 338 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-health-care--series-c~asia.csv461 rows × 18 columns
CompanyCityLast roundAmountDate
CureBayBhubaneshwarSeries C$7.3M2026-10-22
CaredocGangneungSeries C$39.3M2026-10-15
Nat HabitGurgaonSeries C$14.7M2026-10-10
Nutshell TherapeuticsShanghaiSeries C$40.0M2026-09-15
QL BiopharmaBeijingSeries C$44.7M2026-09-14
NuaMumbaiSeries C$50.0M2026-09-07
Kossel MedicalSuzhouSeries C$59.5M2026-09-01
AusperBioHangzhouSeries C$120.0M2026-08-27

8 rows of the CSV in 5 of its 18 columns.

461
Startups
$14.1B
Total raised
60
Funded in the last 12 months
$1.6B
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

30 of 461
30 rows
Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
CureBay CureBay provides healthcare, telemedicine, diagnostics, and pharmacy services. Artificial intelligence Bhubaneshwar, India Series C $7.3M 2026-10-22 $45.1M Elevar Equity 501 to 1,000 2021
Caredoc Caredoc runs an online platform that provides information on proven elderly care facilities. Health care Gangneung, South Korea Series C $39.3M 2026-10-15 $113.3M TIPS Program, Korea Credit Guarantee Fund, Lotte Ventures 11 to 50 2018
Nat Habit Nat Habit is a beauty and wellness brand that sells natural skincare products. Health care Gurgaon, India Series C $14.7M 2026-10-10 $30.9M Titan Capital, Surge, Whiteboard Capital +1 101 to 250 2018
Nutshell Therapeutics Nutshell Therapeutics discovers small-molecule drugs using insights from protein dynamics. Artificial intelligence Shanghai, China Series C $40.0M 2026-09-15 $75.2M Matrix Partners China, Source Code Capital, Northern Light Venture Capital +1 51 to 100 2013
QL Biopharma QL Biopharma develops recombinant protein drugs to treat chronic metabolic diseases. Biotech Beijing, China Series C $44.7M 2026-09-14 $173.7M Chengdu Science and Technology Venture Capital, TF Capital, Lichen Capital +1 101 to 250 2018
Nua Nua sells customizable sanitary products as part of its women's wellness and hygiene brand. Commerce Mumbai, India Series C $50.0M 2026-09-07 $66.5M Kae Capital, Lightbox 51 to 100 2017
Kossel Medical Kossel Medical develops and manufactures vascular interventional devices and clinical system solutions. Health care Suzhou, China Series C $59.5M 2026-09-01 $103.0M Fortune Venture Capital, Suzhou International Development Venture Capital, Ming Bioventures +1 501 to 1,000 2013
AusperBio AusperBio develops oligonucleotide therapeutics and targeted delivery technologies for treating diseases. Biotech Hangzhou, China Series C $120.0M 2026-08-27 $357.0M Qiming Venture Partners, BioVenture, Hankang Capital +1 51 to 100 2019
Diyingjia Technology Diyingjia Technology develops artificial intelligence software for medical imaging and treatment applications. Artificial intelligence Beijing, China Series C $3.0M 2026-07-28 $32.3M IDG Capital, Legend Capital, Microsoft Accelerator 11 to 50 2017
Delova Biotech Delova Biotech develops treatments for pain management. Biotech Qixia, China Series C $88.6M 2026-07-22 $109.8M Legend Capital, Peakview Capital, Hyfinity Investments +1 51 to 100 2017
Weikaier Pharmaceutical Technology Weikaier Pharmaceutical Technology conducts drug research, transfers generic drug technology, and produces and sells pharmaceuticals. Biotech Nanjing, China Series C $29.6M 2026-06-02 $120.4M SDIC Venture Capital, Dyee Capital, Nanjing Innovation Capital Group +1 501 to 1,000 2010
YolTech Therapeutics YolTech Therapeutics combines LNP delivery with gene editing technology for biotechnology applications. Biotech Minhang, China Series C $73.8M 2026-05-29 $144.9M K2VC, UnityVC, Decheng Capital +1 11 to 50 2021
Butterfly Medical Butterfly Medical offers a fast, non-invasive alternative treatment for benign prostate hyperplasia. Health care Yoqne`am `illit, Israel Series C $21.0M 2026-05-14 $30.1M MassChallenge, MedTech Innovator, New Rhein +1 1 to 10 2014
Caring Caring provides visiting medical treatment and senior care services for elderly individuals. Health care Gangneung, South Korea Series C $27.3M 2026-05-08 $84.3M KB Investment, IMM Investment, SV Investment Corp +1 101 to 250 2019
Biobot Surgical Pte Ltd Biobot Surgical provides minimally invasive robotic healthcare solutions worldwide. Fintech Singapore Series C $7.8M 2026-04-09 $39.6M ZIG Ventures 11 to 50 2010
Ruining Bio Ruining Bio provides clinical medical solutions such as tumor radiotherapy protection and wound repair. Health care Jiading, China Series C $14.6M 2026-02-28 $38.8M Qiming Venture Partners, Taiyu Investment, Dingxin Capital +1 2018
Supertails Supertails runs a digital pet care platform offering pet products, services, and online veterinary consultations. Health care Bangalore, India Series C $30.0M 2026-02-09 $58.4M Titan Capital, Alteria Capital, Whiteboard Capital +1 101 to 250 2021
Pee Safe Pee Safe makes hygiene products, such as sanitary and personal care items, for customers across India. Health care Gurgaon, India Series C $32.0M 2026-01-14 $44.7M Venture Catalysts, Rainmatter Capital 101 to 250 2013
Zenitar Zenitar conducts drug research and biomedical technology industrialization. Biotech Chengdu, China Series C $86.0M 2026-01-12 $155.7M Si Chuan Venture Capital, Chengdu High-tech Ceyuan Capital, New Value Capital 51 to 100 2019
Darwin Cell Biology Darwin Cell Biology provides cell biotechnology services. Biotech Beijing, China Series C $27.9M 2025-12-08 $62.4M Shijingshan Modern Innovation Industry Fund, Shanghai Yungu Investment 11 to 50 2016
AITRICS AITRICS delivers AI-powered medical software that helps clinicians detect and prevent critical patient deterioration. Artificial intelligence Seoul, South Korea Series C $23.8M 2025-12-01 $50.9M Springcamp, HB Investment, Premier Partners +1 51 to 100 2016
Healsun Biopharm Healsun Biopharm provides antibody and recombinant protein CRO and CDMO services. Biotech Hangzhou, China Series C $27.8M 2025-11-19 $101.3M Yinxinggu Capital, Haitong Capital, Dongfang Jiafu +2 251 to 500 2015
GRIT Biotechnology GRIT Biotechnology develops tumor infiltrating lymphocyte immunotherapy for solid tumors. Biotech Shanghai, China Series C $84.0M 2025-10-14 $153.5M Matrix Partners China, Hillhouse Investment, CICC +2 51 to 100 2019
Yantai Lannacheng Biotechnology Yantai Lannacheng Biotechnology develops Class I diagnostic medications. Biotech Yantai, China Series C $41.8M 2025-07-20 $103.8M Shenzhen Capital Group, Qianhai Fund of Funds, Yuanhe Capital +1 1 to 10 2021
Tianchen Biotechnology Tianchen Biotechnology develops and sells medical products for ophthalmology. Biotech Tianjin, China Series C $27.8M 2025-06-03 $41.7M CMB International Capital Corporation 2018
LongBio Pharma LongBio Pharma develops treatments for patients with complement and allergy diseases. Biotech Pudong, China Series C $28.9M 2025-05-27 $51.1M Oriental Fortune Capital, Shanxi Securities Investment, Hefei Hongda +2 11 to 50 2020
CURAUM CURAUM makes oral care and sleep-related health care products. Health care Daejeon, South Korea Series C $14.6M 2025-05-25 $23.3M TIPS Program, Korea Credit Guarantee Fund, Lotte Ventures 11 to 50 2017
Foxtale Foxtale sells skincare products suited to all skin types. Health care Mumbai, India Series C $30.0M 2025-01-15 $67.1M Z47, Kae Capital, Stride Ventures 51 to 100 2021
Imagoworks Imagoworks develops AI and cloud-based 3D dental and medical software. Artificial intelligence Seocho, South Korea Series C $15.6M 2024-12-31 $25.9M KB Investment, Company K Partners, LB Investment +2 51 to 100 2019
NitiNotes NitiNotes develops the EndoZip automated suturing device for obesity treatment. Health care Caesarea, Israel Series C $9.3M 2024-12-23 Elron Ventures, Peregrine Ventures, MTIP AG 11 to 50 2014

Table 1. Health care startups that raised Series C in Asia: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 461.

Largest rounds

Last 12 months
10 rows
# Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
1 AusperBio AusperBio develops oligonucleotide therapeutics and targeted delivery technologies for treating diseases. Biotech Hangzhou, China Series C $120.0M 2026-08-27 $357.0M Qiming Venture Partners, BioVenture, Hankang Capital +1 51 to 100 2019
2 Delova Biotech Delova Biotech develops treatments for pain management. Biotech Qixia, China Series C $88.6M 2026-07-22 $109.8M Legend Capital, Peakview Capital, Hyfinity Investments +1 51 to 100 2017
3 Zenitar Zenitar conducts drug research and biomedical technology industrialization. Biotech Chengdu, China Series C $86.0M 2026-01-12 $155.7M Si Chuan Venture Capital, Chengdu High-tech Ceyuan Capital, New Value Capital 51 to 100 2019
4 YolTech Therapeutics YolTech Therapeutics combines LNP delivery with gene editing technology for biotechnology applications. Biotech Minhang, China Series C $73.8M 2026-05-29 $144.9M K2VC, UnityVC, Decheng Capital +1 11 to 50 2021
5 Kossel Medical Kossel Medical develops and manufactures vascular interventional devices and clinical system solutions. Health care Suzhou, China Series C $59.5M 2026-09-01 $103.0M Fortune Venture Capital, Suzhou International Development Venture Capital, Ming Bioventures +1 501 to 1,000 2013
6 Nua Nua sells customizable sanitary products as part of its women's wellness and hygiene brand. Commerce Mumbai, India Series C $50.0M 2026-09-07 $66.5M Kae Capital, Lightbox 51 to 100 2017
7 QL Biopharma QL Biopharma develops recombinant protein drugs to treat chronic metabolic diseases. Biotech Beijing, China Series C $44.7M 2026-09-14 $173.7M Chengdu Science and Technology Venture Capital, TF Capital, Lichen Capital +1 101 to 250 2018
8 Nutshell Therapeutics Nutshell Therapeutics discovers small-molecule drugs using insights from protein dynamics. Artificial intelligence Shanghai, China Series C $40.0M 2026-09-15 $75.2M Matrix Partners China, Source Code Capital, Northern Light Venture Capital +1 51 to 100 2013
9 Caredoc Caredoc runs an online platform that provides information on proven elderly care facilities. Health care Gangneung, South Korea Series C $39.3M 2026-10-15 $113.3M TIPS Program, Korea Credit Guarantee Fund, Lotte Ventures 11 to 50 2018
10 Pee Safe Pee Safe makes hygiene products, such as sanitary and personal care items, for customers across India. Health care Gurgaon, India Series C $32.0M 2026-01-14 $44.7M Venture Catalysts, Rainmatter Capital 101 to 250 2013

Table 2. Health care startups that raised Series C in Asia: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Shenzhen Capital Group Venture capital firm Nanshan, China 5 1%
2 Matrix Partners China Venture capital firm Beijing, China 4 1% 1 Nutshell Therapeutics
3 Qiming Venture Partners Venture capital firm Shanghai, China 4 1% 2 AusperBio, Ruining Bio
4 Legend Capital Venture capital firm Beijing, China 4 1% 2 Diyingjia Technology, Delova Biotech
5 OrbiMed Private equity firm New York, United States 4 1% 1 Shenluo Medical
6 Shanghai Biomedical Industrial Equity Investment Fund Venture capital firm Huangpu, China 4 1% 1 Healsun Biopharm
7 Hillhouse Investment Angel group Singapore 4 1%
8 SMBC Venture Capital Corporate venture arm Tokyo, Japan 4 1%
9 Shenzhen Guozhong Venture Capital Management Venture capital firm Shenzhen, China 4 1%
10 TIPS Program Startup incubator Gangneung, South Korea 3 1% 1 Caredoc
11 Fireside Ventures Micro VC fund Bangalore, India 3 1% 2 Nat Habit, Supertails
12 Whiteboard Capital Venture capital firm Mumbai, India 3 1% 2 Nat Habit, Supertails
13 Baidu Ventures Venture capital firm Beijing, China 3 1% 1 Nutshell Therapeutics
14 Northern Light Venture Capital Venture capital firm Beijing, China 3 1% 1 Nutshell Therapeutics
15 Fortune Venture Capital Venture capital firm Shenzhen, China 3 1% 1 Kossel Medical

Table 3. Health care startups that raised Series C in Asia: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Biotech 205 44% $7.9B
Software 56 12% $1.1B
Artificial intelligence 27 6% $547.6M
Hardware 24 5% $562.5M
Commerce 12 3% $94.5M
Fintech 6 1% $51.8M
Education 4 1% $114.7M
Energy 3 1% $154.5M

Table 4. Health care startups that raised Series C in Asia by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series C 461 100% $18.0M

Table 5. Health care startups that raised Series C in Asia by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Countries

CountriesCompaniesShare
China 309 67%
South Korea 52 11%
Japan 31 7%
Israel 27 6%
India 22 5%
Singapore 9 2%
Taiwan 5 1%
United Arab Emirates 2 0%
Indonesia 1 0%
Hong Kong 1 0%
Thailand 1 0%
Jordan 1 0%

Table 6. Health care startups that raised Series C in Asia by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Shanghai 50 11%
Beijing 43 9%
Hangzhou 33 7%
Shenzhen 25 5%
Suzhou 23 5%
Seoul 20 4%
Nanjing 18 4%
Guangzhou 17 4%
Tokyo 16 3%
Haidian 12 3%
Mumbai 8 2%
Singapore 8 2%

Table 7. Health care startups that raised Series C in Asia by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
October 2026 5 8% $116.2M
September 2026 5 8% $234.2M
August 2026 3 5% $157.1M
July 2026 6 10% $192.2M
June 2026 3 5% $73.8M
May 2026 9 15% $243.6M
April 2026 4 7% $131.4M
March 2026 7 12% $83.1M
February 2026 5 8% $132.6M
January 2026 4 7% $118.0M
December 2025 8 13% $88.7M
November 2025 1 2% $27.8M

Table 8. Health care startups that raised Series C in Asia: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 51 11% $1.5B
2025 55 12% $1.1B
2024 50 11% $623.2M
2023 45 10% $841.2M
2022 47 10% $892.4M
2021 77 17% $3.8B

Table 9. Health care startups that raised Series C in Asia by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2020 to 2022 20 4%
2015 to 2019 211 46%
2010 to 2014 151 33%
Before 2010 76 17%

Table 10. Health care startups that raised Series C in Asia by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 37 8%
11 to 50 136 31%
51 to 100 87 20%
101 to 250 82 19%
251 to 500 42 10%
501 to 1,000 31 7%
1,001 to 5,000 19 4%
5,001 to 10,000 2 0%
10,001 or more 1 0%

Table 11. Health care startups that raised Series C in Asia by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many health care startups in Asia whose last round is Series C are on the list?
461, in the file dated 16 November 2026. 60 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 461 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Health care startups that raised Series C in Asia: 461 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Health care at other stages in Asia

Other sectors that raised Series C in Asia

Cite: FundingWatcher, 461 health care companies in Asia whose most recent round is Series C, 16 November 2026. https://fundingwatcher.com/startups/health-care/series-c/asia/